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Abstract
Joubert syndrome and related diseases (JSRD) are developmental cerebello-oculo-renal syndromes with phenotypes
including cerebellar hypoplasia, retinal dystrophy and nephronophthisis (a cystic kidney disease). We have utilised the MRC-
Wellcome Trust Human Developmental Biology Resource (HDBR), to perform in-situ hybridisation studies on embryonic
tissues, revealing an early onset neuronal, retinal and renal expression pattern for AHI1. An almost identical pattern of
expression is seen with CEP290 in human embryonic and fetal tissue. A novel finding is that both AHI1 and CEP290
demonstrate strong expression within the developing choroid plexus, a ciliated structure important for central nervous
system development. To test if AHI1 and CEP290 may have co-evolved, we carried out a genomic survey of a large group of
organisms across eukaryotic evolution. We found that, in animals, ahi1 and cep290 are almost always found together;
however in other organisms either one may be found independent of the other. Finally, we tested in murine epithelial cells
if Ahi1 was required for recruitment of Cep290 to the centrosome. We found no obvious differences in Cep290 localisation
in the presence or absence of Ahi1, suggesting that, while Ahi1 and Cep290 may function together in the whole organism,
they are not interdependent for localisation within a single cell. Taken together these data support a role for AHI1 and
CEP290 in multiple organs throughout development and we suggest that this accounts for the wide phenotypic spectrum
of AHI1 and CEP290 mutations in man.
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Introduction
Joubert syndrome and related diseases (JSRD) are a group of
inherited ciliopathies, characterised by a cerebello-retinal-renal
phenotype. The brain phenotype is a developmental midbrain
malformation leading to cerebellar vermis hypoplasia or aplasia,
and seen in brain MRI imaging as a ‘‘molar tooth sign’’ [1]. Other
structural brain defects including hypoplasia of the corpus
callosum and occipital meningoencephalocele have been reported
[2,3].
Retinal dysplasia and degeneration occur in a proportion of
patients and may lead to progressive blindness [1,4,5]. Ocular
coloboma may also be a feature [6]. Renal disease is variable, with
nephronophthisis [7] and multicystic dysplasia [8] as reported
phenotypes, which may lead to end stage renal failure. Consistent
with JSRD as a ciliopathy are the findings of polydactaly and liver
fibrosis [9,10].
In keeping with the clinical heterogeneity of JSRD, 16 causal
genes, have been identified in patients. These include INPP5E
[11], TMEM2169 [12], AHI1 [7,13,14], NPHP1 [15], NPHP6
(CEP290) [3], TMEM67 [16], RPGRIP1L [8], ARL13B [17],
CC2D2A [18], CXORF5 [19], TTC21B [20], KIF7 [21], TCTN1
[22], TMEM237 [23], CEP41 [24] and TMEM138 [25]. Defects in
these genes produce phenotypes that may be termed ciliopathies,
given that the protein products encoded by all of these genes have
been localised in the basal body, centrosome or primary cilium
[10], a highly conserved cellular organelle, central to the
regulation of cellular signalling pathways [26].
Mutations in AHI1 and CEP290 are both a frequent causes of
Joubert syndrome and genetic variants in both genes may act as
modifier alleles, especially in regard to a retinal and CNS
phenotype [27,28]. Mutations in AHI1 (Abelson-helper integration
site-1) are the most common genetic cause of JSRD, accounting
for 12% of cases and 20% of individuals with Joubert syndrome
and Leber’s congenital amaurosis [13,14,29,30,31].
AHI1 is highly conserved throughout evolution and encodes the
Ahi1 protein (also known as Jouberin). We have previously
demonstrated that Ahi1 localises to centrosomes/basal bodies of
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renal epithelial cells, and that it interacts with the nephrocystin-1
protein [32]. At a genomic level, there is evidence for AHI1
mutations/polymorphisms having an oligogenic effect and mod-
ulating the phenotype. For example Tory et al. describe 5 patients
with homozygous NPHP1 mutations together with a R830W
mutation in AHI1, which leads to a more severe central nervous
system defect [27]. Similarly, the relative risk (RR) of a retinal
defect associated with nephronophthisis was significantly increased
(RR=7.5 (95% CI 4.0–11.2)) in the presence of the R830W AHI1
mutation [31].
Mutations in CEP290 may cause a wide spectrum of human
disease ranging from isolated Leber’s congenital amaurosis to
JSRD, Meckel syndrome (MKS) and Bardet-Biedl syndrome (BBS)
[33,34,35]. Renal disease is common in patients with CEP290
mutations, and may be secondary to NPHP and renal cortical cysts
[3,36].
CEP290 mutations account for around 50% of cases of JSRD
with renal and retinal disease [3,27,36,37,38,39,40]. Some
additional phenotypes in patients with CEP290 mutations have
included occipital encephaloceles [3] and septal heart defects [37].
CEP290 mutations are a common cause of isolated Leber’s
congenital amaurosis, accounting for ,20% of patients [39,41].
CEP290 is highly conserved throughout evolution and encodes
the Cep290 protein (also known as nephrocystin-6) [3]. We have
previously demonstrated that Cep290 localises to centrosomes/
basal bodies of renal epithelial cells and that it interacts with ATF4
[3]. Additional CEP290/Cep290 interactions include a genetic
interaction with CC2D2A [18] and protein complex interactions
with CP110 and Rab8a [42]. In a similar manner to patients with
NPHP1 mutations, there is some evidence that alleles of AHI1 may
also modify the neurological phenotype of patients with CEP290
mutations [28].
Given this evidence implicating an important role for CEP290
and AHI1 in modulating brain, eye and other phenotypes in
JSRD, we sought to identify the pattern of both AHI1 and CEP290
expression in kidney and central nervous system during develop-
ment. Using human embryonic and fetal tissue we describe the
expression pattern of AHI1 and CEP290 during stages of human
renal and brain development (Table 1).
To determine whether AHI1 and CEP290 may have co-evolved,
we performed a genomic survey of a large group of organisms
across eukaryotic evolution. We also explored whether Ahi1 was
required for recruitment of Cep290 to the centrosome.
Our novel data emphasises the important and extensive role of
AHI1 and CEP290 in vertebrate development, from essential
cellular signalling organelles, such as the primary cilium, to
complex organ systems such as the brain and kidney.
Materials and Methods
Ethics statement
This study was conducted with full ethical approval. For human
embryonic and fetal tissue samples, the samples were collected
with appropriate maternal consents and ethical approval by the
Newcastle and North Tyneside 1 Research Ethics Committee,
UK.
Human tissue in-situ hybridisation
Human embryonic and fetal tissues were obtained from the
MRC/Wellcome Trust-funded Human Developmental Biology
Resource (http://www.hdbr.org; [43]). In situ hybridisation was
performed on human embryo paraffin sections as previously
described [44] with some modifications. Briefly, sections were
dewaxed in xylene, gradually hydrated in decreasing ethanol
concentrations before incubation in Proteinase K (20 mg/ml) at
room temperature (RT), followed by fixation in 4% paraformal-
dehyde in PBS. Background was reduced by treating with 0.1 M
Triethanolamine pH 8. Sections were air dried and probe added
(300 ng labeled probe per 100 ul of Dig Easy Hyb mix (Roche)) at
68uC overnight. The next day sections were washed once in 56
SSC then once in 26 SSC at 60uC then incubated with anti-
digoxigenin AP Fab fragments (Roche) diluted 1:1000 at 4uC
overnight. Sections were then washed and expression detected
using NBT/BCIP (20 ul/ml Roche) in 0.1 M Tris/0.1 M NaCl
(pH 9.5) in the dark at room temperature. Developing was stopped
by rinsing slides first in 0.1 M Tris/0.1 M NaCl (pH 9.5) then in
deionised H2O. Sections were mounted using Aquamount.
Samples from Carnegie stage (CS) 12 (,26 days post conception
(dpc)) to 9 weeks post conception (PCW) were used (CS12 (N548);
CS14 (N663, N7120); CS15 (N734); CS16 (N218); CS17 (N1247);
CS19 (N470); CS20 (N590); CS22 (N225, N2188); CS23 (N300); 9
PCW (N477, N9223)). Sections from 13 different embryos/fetuses
were used in total.
In situ hybridisation probes for human expression studies of
AHI1 were generated using PCR and subcloning into pGEM-
Teasy vectors. All clones were sequenced to confirm orientation
with respect to T7 and SP6 promoters. Both sense and antisense
RNA probes were produced by in vitro transcription from the T7
and SP6 RNA polymerase sites respectively of the pGEM-T Easy
vector. Probes were generated from two regions of the AHI1 gene
(BC094800), nucleotides 1 to 276 (in 59UTR) and nucleotides
2105 to 2635 (in 39UTR) using the ‘‘Riboprobe’’ system
(Promega). Both probe sets gave similar patterns however the
59UTR probe set gave a higher background in preliminary
experiments (data not shown). The 39UTR probe set was used for
all the experiments reported here.
In situ hybridisation probes for human expression studies of
CEP290 were generated from two regions of CEP290
(NM_025114) using the ‘‘Riboprobe’’ system (Promega) as above:
nucleotides 675 to 1381 and 6265 to 6924 (both in the coding
sequence). Although a similar pattern was detected with both
antisense probes, there was a higher background with the 675 to
1381 nucleotide sense probe (data not shown). The 6265 to 6924
nucleotide probe set was used for all the experiments reported
here.
Antisense probes for sonic hedgehog (SHH, NM_000193) were
used as a positive control. The SHH probe, which contains
nucleotides from 460 to 950, showed the expected specific staining
in the spinal cord and notochord (data not shown). Antisense RNA
probe of developing brain homeobox 1 (DBX1, NM_001029865)
transcribed from nucleotides 308 to 830 which shows specific
staining at the sulcus limitans of spinal cord was also used as an
experimental control (data not shown). Expression patterns were
analysed using the Axioplan 2 imaging system (Zeiss).
Sequence analysis
Putative Ahi1 and Cep290 orthologues were identified using a
combination of reciprocal best BLASTP and PSI-BLAST, with
human Ahi1 (isoform a, NP_001128302.1) and Cep290
(NP_079390.3) as the query sequences [45,46]. The initial Ahi1
search generated a very large number of false positives, which
were only similar in terms of WD40 repeats. To overcome this
problem, we performed further searches using human Ahi1 amino
acids 1–545. These protein sequences were used to query the non-
redundant predicted proteomes of 44 organisms (33 flagellate, 11
non-flagellate) chosen to represent a wide evolutionary spread of
eukaryotes. Searches were carried out using the NCBI stand-alone
BLAST+ application (version 2.2.25+, [47]) against BLAST-
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formatted genomes from a variety of sources (see Supplementary
Figure S1). We used the following criteria to define a putative Ahi1
or Cep290 orthologue: 1) An e-value less than 1e-05 (BLASTp) or
1e-10 (PSI-BLAST), 2) A reciprocal BLAST which returns the
original sequence, and 3) Manual examination of sequences and
alignments constructed using MAFFT [48].
Cell culture, siRNA, and immunofluorescence using
mIMCD-3 cells
Mouse inner medullary collecting duct (IMCD-3) cells were
cultured in DMEM/Ham’s F12 supplemented with 10% fetal calf
serum (Sigma–Aldrich Co. Ltd., Poole, UK). For functional
analyses, passage 16–17 IMCD3 cells were cultured on 13 mm
glass coverslips. Cells were transfected with a pool containing
100 pmol of each of four siRNA duplexes (OnTargetPlus
SMARTpool, Dharmacon) against mouse Ahi1 at 60–70%
confluency using Lipofectamine 2000 according to our previously
established methods [49]. The medium GC non-targeting control
(Invitrogen) was used as a negative control. siRNAs were as
follows: oligo 1 59-GGUCAAAAGACGAUCGCUA-39, oligo 2
59-UGAAGUUAGCCGCCGUGUAA-39, oligo 3 59-
GCUAAAUGUCGUCGAGGUU-39, oligo 4 59-GUGAAACA-
CUGUAUCGAGA-39. As a further control, siRNA studies were
repeated with two individual siRNA oligonucleotides (numbers 2
and 3, above, data not shown). We have previously characterised
these duplexes in this same cell line and demonstrated successful
siRNA knockdown [49]. Transfected cells were identified using co-
transfection with siGLO red (Dharmacon). Transfection efficiency
was estimated at 75–80%. Immunofluorescence was carried out
72 hours after transfection using anti-Cep290 (Abcam, ab84870)
and anti-gamma tubulin (clone GTU-88, Sigma Aldrich) followed
by goat anti-mouse AlexaFluor 488 and 647 (Molecular Probes).
Samples were visualised using a Zeiss LSM510 confocal micro-
scope controlled by LSM examiner software (Carl Zeiss). Images
were processed in ImageJ to produce maximum intensity
projections.
Results
AHI1 expression during human brain and kidney
development
There has been no previous documentation of AHI1 spatial
expression during development in human tissue. Previous char-
acterisation has been limited to hybridisation to RNA northern
blot showing expression in fetal brain, kidney, liver and lung
[13,14] and Western blotting, demonstrating Ahi1 protein
expression in fetal cerebellum and spinal cord [50].
Using specific probes targeted towards nucleotides 2105 to 2635
of AHI1 mRNA we observed a strong and specific pattern of
expression in the brain and spinal cord from CS16 to CS23
(Figure 1; see also Table 1 for developmental overview). AHI1
expression was abundant in the developing telencephalon
(Figure 1B), especially the neuroepithelium, and in the neural
retina (Figure 1C, D respectively). Strikingly, we observed
expression within the choroid plexus (Figure 1I, J). Prominent
expression was also seen in the mesencephalon and throughout the
developing hindbrain (metencephalon and myelencephalon,
Figure 1F–H) including the rhombic lip of the developing
cerebellum (Figure 1H). There was particularly prominent staining
within the alar plate of the spinal cord as well as in the spinal and
other ganglia of the peripheral nervous system (Figure 1K, L).
SHH and DBX1 antisense probes were used as positive controls
and the expected patterns of expression were seen in the
developing spinal cord (data not shown).
AHI1 expression during human nephrogenesis was examined
from stages CS14 through to 9 PCW (Figure 2). These studies
revealed that AHI1 transcripts are abundant in both the
developing mesonephros and metanephros. Extra renal sites of
Table 1. Overview of renal and brain development time points in human embryogenesis.
Carnegie Stage Approximate age (dpc) Kidney development Brain development
CS12 26 The mesonephros begins to form Formation of neural tube with primordial brain at
rostral end consisting of three primary brain
vesicles (primary forebrain, midbrain and
hindbrain)
CS14 32 The metanephros starts to form deep in
the pelvic region; ureteric buds are
identifiable; glomeruli are visible in the
mesonephros
Forebrain is divided into telencephalon and
diencephalon, optic cup usually present,
rhombomeres 1–8 visible in hind brain
CS15 33 Cerebral hemispheres start to develop in
telencephalon
CS16 37 Metanephros ascends through the
abdominal cavity
CS17 41 Glomeruli now visible in metanephros First appearance of choroid plexus in
telencephalon
CS19 47.5 Early stages of cerebellum formation
CS20 50.5 Collecting ducts now visible in
metanephros
CS21 52 Cortical plate appears in cerebral hemispheres
CS22 54 Mesonephros starts to degenerate
CS23 56 Cortical plate present throughout cerebral cortex;
external germinal layer visible in the cerebellum
9 PCW 57–63 Distinct regions become visible in
metanephros
doi:10.1371/journal.pone.0044975.t001
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expression included prominent staining of the embryonic liver and
embryonic gonad (Figure 2D, F). Detailed studies through
mesonephric development showed discrete AHI1 expression in
the mesonephric excretory unit at CS12 (data not shown) and
CS14–CS22 (Figure 2G). By CS23, AHI1 expression was visible in
degenerating glomeruli of the mesonephros and at 9 PCW,
expression was detectable in the mesonephric tubule, ducts and
paramesonephric duct, structures that will form parts of the future
reproductive system (Figure 2G/CS23 and 2G/9PCW respective-
ly). AHI1 expression was seen in early (permanent) metanephric
kidney (Figure 2H) with intense staining in the metanephric cap
and ureteric bud at CS14 and CS16. By CS22 and later,
developing glomeruli, tubules and collecting ducts strongly
expressed AHI1 (Figure 2H).
More detailed analysis of AHI1 expression at 9 PCW revealed
intense staining in both tubular epithelium and glomerular
structures (Figure 2H/9 PCW). Expression was seen in cortical
and medullary epithelium, including the epithelium lining of the
renal calyces. Glomerular staining was intense in a subset of cells
whilst there was an absence of expression in the renal interstitium,
indicating low levels of AHI1 transcript in interstitial cells and
vascular endothelium.
Thus, in human tissue AHI1 is strongly expressed in all
developing renal tissues from the mesonephros to the precursors
of the adult kidney, with a broad expression throughout the
nephron and collecting ducts during renal development.
CEP290 expression during human brain and kidney
development
The CEP290 spatial expression during development in human
tissue has not previously been reported. Previous characterisation
has been limited to hybridisation to RNA northern blot of adult
tissues showing expression of a major CEP290 transcript of
approximately 8 kb that is expressed strongly in placenta and
weakly in adult brain [3].
Using specific probes targeted towards nucleotides 6265 to 6924
of CEP290 mRNA we observed a strong and specific pattern of
expression in the brain and spinal cord from CS16 to CS22
Figure 1. AHI1 is expressed in the developing cerebellum, spinal cord, choroid plexus and eye. (A, E) Negative control hybridisation with
AHI1 sense RNA probe and (B–D) hybridisation with AHI1 antisense RNA probe to transverse sections at CS22. AHI1 transcripts are abundant in the
developing telencephalon, especially the neuroepithelium (C) and neural retina (D). Prominent expression is seen in (F–H) metencephalon (including
cerebellum), myelencephalon and mesencephalon at CS19. Strong expression is detected in the neuroepithelium of the developing mesencephalon
and cerebellum (G, H). Within the developing ventricles, strong expression is seen in the choroid plexus epithelium (I, J) and the neuroepithelium of
the ganglionic eminences at CS23 (I). Prominent staining is demonstrated within (K) the alar plate of spinal cord at CS16 and (L) CS22 and in the spinal
ganglia. Ap, alar plate; Bp, basal plate; GE, ganglionic eminence; NEP, neuroepithelium; Cor.NEP: cortical neuroepithelium; Mes.NEP: mesencephalic
NEP; Cere.NEP: cerebellar NEP; CP: choroid plexus; CPE, choroid plexus epithelium; Mes, mesencephalon (midbrain); Met, metencephalon; Mye,
myelencephalon; NR, neural retina; OS, optic stalk; URhoL, upper rhombic lip; RPE, retinal pigment epithelium; Sc, spinal cord; SG, spinal ganglion;
SyG, sympathetic ganglion; T, telencephalon; Ton, tongue; VG, vagal ganglion. Scale bars: A, B, E, F = 2 mm; C, D, G, H, K = 500 mm; I = 1 mm;
J = 250 mm; L = 500 mm.
doi:10.1371/journal.pone.0044975.g001
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(Figure 3). CEP290 expression was seen in the developing
telencephalon (Figure 3B), especially the neuroepithelium, and in
the neural retina (Figure 3C, D respectively). Prominent expres-
sion was seen in the choroid plexus (Figure 3E, F) and throughout
the developing hindbrain (Figure 3H). Expression of CEP290 is
also seen in the rhombic lip of the developing cerebellum
(Figure 3H) and the mesencephalic and cerebellar neuroepitheli-
um (Figure 3I, J). In the spinal cord there was particularly
prominent staining within the alar plate and some staining of the
spinal and sympathetic ganglia (Figure 3K, L). This expression
pattern seen in the developing human brain with CEP290 mirrors
the pattern seen for AHI1 (compare Figure 1 with Figure 3).
CEP290 expression during human nephrogenesis was examined
from CS12 through to 9 PCW (Figure 4). CEP290 transcripts are
abundant in both the developing mesonephros and metanephros
(Figure 4E, F). Specific areas of CEP290 expression are seen in the
mesonephric excretory unit at CS12–CS23 (Figure 4E). By 9
PCW, CEP290 expression was seen in early (permanent)
metanephric kidney with intense staining in the developing
glomeruli, tubules and collecting ducts (Figure 4F, 4E/9PCW).
Thus, like AHI1, CEP290 is strongly expressed in the mesonephros
and metanephros precursors of the adult kidney. Similar to AHI1,
expression of CEP290 was low/absent in the renal interstitium.
AHI1 and CEP290 are highly evolutionarily conserved and
are generally present together in animal genomes
This great similarity of expression in humans prompted us to
ask if AHI1 and CEP290 might have co-evolved. We have
previously shown using a reciprocal BLASTp approach that AHI1
is highly evolutionarily conserved, and is restricted to the genomes
of ciliated organisms [49]. Given the strong overlap in expression
between AHI1 and CEP290, we extended this analysis using PSI-
BLAST and reciprocal BLASTp to identify additional homo-
logues. We searched the predicted proteomes of 44 eukaryotic
organisms chosen to represent a wide evolutionary spread of
organisms, both ciliated (33 organisms) and non-ciliated (11
organisms). Both ahi1 and cep290 evolved prior to the evolution of
multicellularity, are conserved from ciliated protozoa to man, and
are restricted to the genomes of organisms that build cilia or
flagella (Supplementary Figure S1). Putative orthologues of both
AHI1 and CEP290 were present in the genomes of organisms that
build only sensory cilia (Daphnia, Tribolium) as well as in the
genomes of organisms that build either motile cilia/flagella only,
or both motile and sensory cilia, implying that both ahi1 and
cep290 are required for basal body/cilium function in cells with
motile cilia and cells with sensory cilia. Building on our previous
observation that ahi1 was only present in the genomes of organisms
Figure 2. AHI1 expression during nephrogenesis. (A, C, E) AHI1 sense RNA probe and (B, D, F) AHI1 antisense RNA probe hybridised to sections
from (A, B) CS16; (C, D) CS22 and (E, F) 9 PCW. AHI1 transcripts are abundant in the mesonephros (Meso) and metanephros (Meta) of the developing
kidney as well as the spinal cord (Sc), liver and embryonic gonad. (G, H). A series of sections at different stages of mesonephric and metanephric
development. AHI1 expression is seen in (G) mesonephric excretory unit - a mesonephric tubule, glomerulus and duct at CS14, CS16 and CS22. By
CS23 expression is visible in degenerating glomeruli (DG). By 9 PCW expression is detectable in the mesonephric tubule, ducts and paramesonephric
duct. AHI1 expression is seen in (H) early permanent metanephric kidney with intense staining in the metanephric cap and ureteric bud (CS14 and
CS16). By CS22 and later developing glomeruli, tubules and collecting ducts are seen to strongly express AHI1 (CS22, CS23 and 9 PCW). In 9 PCW
human fetal sections, AHI1 transcripts are abundant in the developing nephrons and collecting ducts of renal cortex and there is weak expression in
medulla/renal pelvis. CD, collecting duct; DG, degenerating glomerulus; Gl, glomerulus; H, hindgut; LL, lower limb; Mc, metanephric cap; Md,
mesonephric duct; Med, renal medulla; Meso, mesonephros; Meta, metanephros; Mt, mesonephric tubule; P, renal pelvis; Pmeso, paramesonephric
duct; Sc, spinal cord; St, stomach; UB, ureteric bud; UL, upper limb. Scale bars: A–F= 2 mm; G: CS16= 500 mm; CS14, CS23 & 9WPC=250 mm;
CS22= 125 mm; H: CS22 & 9WPC= 500 mm; CS14, CS16 & CS23= 250 mm.
doi:10.1371/journal.pone.0044975.g002
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that build a canonical nine-triplet centriole [49], both ahi1 and
cep290 were absent from the genome of Toxoplasma gondii and the
two nematode genomes in our study, which all build specialised,
non-canonical centrioles. Therefore, ahi1 and cep290 may both be
required for triplet centriole function. In animals, ahi1 and cep290
were both found in all organisms except in Dipthera (Anopheles and
Drosophila) and Gallus, indicating a possible common function in
metazoa that is consistent with the expression data. However,
while there was a general trend for ahi1 and cep290 to both be
present in a given genome, this was not invariable. We found only
a predicted AHI1 orthologue in 5 genomes (Aureococcus anophagef-
ferens, Naegleria gruberi,, Trichomonas vaginalis, Trypanosoma brucei) and
only a predicted CEP290 orthologue in a further 5 genomes
(Anopheles gambiae, Drosophila melanogaster, Micromonas pulsilla, Monosiga
brevicollis, Gallus gallus) suggesting that, while ahi1 and cep290 might
function together in animals, they are not co-dependent in all
organisms.
Cep290 does not require Ahi1 for localisation
Cep290 is a 290 kDa protein that is localised at the centrosome
[3,36,42,51]. To examine whether Ahi1 is necessary for correct
recruitment of Cep290 to centrosomes [52,53], we ablated Ahi1
expression using siRNA in IMCD3 renal epithelial cells [49] and
visualised Cep290 and centrosomes using anti-Cep290 and anti-
gamma tubulin immunofluorescence. We examined the appear-
ance of the Cep290 signal at centrosomes throughout the cell.
There was no difference in the distribution of centrosomes
between Ahi1-silenced cells and controls (Figure 5A), indicating
that the centrosome is still able to re-orient to the apical cell
surface in the absence of Ahi1. We found no obvious differences in
the immunofluorescence pattern between control and Ahi1 siRNA-
treated cells (Figure 5B and C), regardless of the centrosome
position within the cell, indicating that Ahi1 and Cep290 are not
interdependent for localisation to centrosomes.
Discussion
We have demonstrated early embryonic expression of AHI1 and
CEP290 in human embryonic tissues, with a remarkable similarity
in expression patterns. Both AHI1 and CEP290 are widely
expressed in multiple tissues, including developing brain, eye,
spinal cord and renal tissues. Previous expression studies in murine
Figure 3. CEP290 is expressed in the developing cerebellum, spinal cord and eye. (A, G) Negative control hybridisation with CEP290 sense
RNA probe and (B–F) hybridisation with CEP290 antisense RNA probe to transverse sections at CS22. CEP290 transcripts are abundant in the
developing telencephalon (B, C, E), especially the cortical neuroepithelium (C), and neural retina (D). CEP290 expression is demonstrated within the
epithelium of the choroid plexus (CP) (E, F) at CS22. Prominent expression is seen in metencephalon (including cerebellum), myelencephalon and
mesencephalon at CS19 (H, I, J). Strong expression is detected at the rhombic lip in the developing cerebellum (H, J), the mesencephalic (I) and
cerebellar neuroepithelium (J). Prominent staining is demonstrated within the alar plate of spinal cord at CS16 (K) and CS22 (L). Ap, alar plate; Bp,
basal plate; CP: choroid plexus; CPE, choroid plexus epithelium; Mes, mesencephalon (midbrain); Met, metencephalon; Mye, myelencephalon; NEP,
neuroepithelium; Cor.NEP: cortical neuroepithelium; Cere.NEP: cerebellar neuroepithelium; Mes.NEP: mesencephalic (midbrain) neuroepithelium; NR,
neural retina; RPE, retinal pigment epithelium, Sc, spinal cord; SG: spinal ganglion; SyG: sympathetic ganglia; T, telencephalon, Ton, tongue; LRhoL:
lower rhombic lip; URhoL: upper rhombic lip; Scale bar: A, B, G, H = 2 mm, C, D, F, K = 500 mm; E = 1 mm; L = 500 mm; I, J = 250 mm.
doi:10.1371/journal.pone.0044975.g003
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tissues showed Ahi1 expression in neurons of the developing
hindbrain/midbrain/forebrain, pituitary, testis and kidney [50].
Ahi1 expression in murine brain was reported during early
embryonic life (day 10.5) and persisted into adult life. Interestingly,
in Doering’s studies, mouse Ahi1 protein expression was not seen
in the developing or mature cerebellum although AHI1 was
present in the human cerebellum, suggesting a species difference
[50]. Indeed, these studies commented that the highest AHI1
expression in adult brain tissue was in the cerebellar vermis and
cerebellar peduncles [50]. A functional role for AHI1 in brain
development is suggested by the numerous structural defects
associated with Joubert syndrome [13,14].
We were able to demonstrate prominent AHI1 expression in the
developing retina. It is now well established that the light sensitive
photoreceptor cells of the retina are specialised sensory cilia.
Inherited forms of retinal degeneration, where these cells are
affected are now a hallmark of diseases termed ciliopathies
[54,55]. Numerous gene defects, encoding proteins expressed in
cilia, may be associated with retinal degeneration. NPHP5
mutations are a prominent cause of retinal degeneration [56].
Ahi12/2 mutant mice fail to develop photoreceptor outer
segments, leading to retinal degeneration [31,57].
Ahi1 was seen to be expressed at the transition zone of
photoreceptor cells of wild-type mice, colocalising with the
transition zone marker Rpgrip1 [57]. The Ahi12/2 murine
model mimics closely the defect seen in JSRD patients with AHI1
mutations [7,9,30]. Our data of human AHI1 expression in retinal
development confirms this requirement of AHI1 for normal
photoreceptor development.
Consistent with the renal phenotype seen in some JSRD
patients [29], we demonstrate for the first time AHI1 and CEP290
expression in the human embryonic kidney. Indeed, murine data
showing detailed kidney expression of these genes is also lacking.
The pattern of expression during development of the mesonephros
and metanephros points to a role in tubulogenesis, epithelial cell
polarity and maintenance of orientated cell division, as has been
described for other ciliary proteins [58].
In human adult kidney, we have previously demonstrated that
Ahi1 protein expression is limited to the distal tubule and
collecting duct nephron segments [32], whilst murine kidney
tissue from a 5 month week old animal revealed Ahi1 expression at
the corticomedullary junction [59]. A postnatal increase in Ahi1
protein expression has also been described [59]. This suggests that
renal Ahi1 expression must be regulated throughout development
and into adult life, and that a role for maintenance of distal tubular
function continues into adult life.
There have been no previous studies documenting the renal
expression of CEP290 in human kidney. Previous studies have
documented expression of murine Cep290, with RNA blot analysis
revealing expression at embryonic day 7 to E17 in whole embryos,
and kidney and brain expression at P0. [36]. In situ hybridisation
studies in murine cerebellum have demonstrated expression in the
external (proliferative) and internal granule layer in the midline at
E18 and the latter expression persists into adulthood [36]. At the
earlier human stages studied here, CEP290 expression is detected
in cerebellar neuroepithelium, also a proliferative layer, as well as
mesencephalic and telencephalic neuroepithelium.
The Cep290 protein has also been localized within photore-
ceptor cells, to the connecting cilium adjoining the outer segment
to the photoreceptor cell body [3,60].
CEP290 mutations are the commonest monogenic form of
Leber’s congenital amaurosis (LCA) [61]. A murine model of
Figure 4. CEP290 is expressed in the developing kidney. Hybridisation with CEP290 antisense RNA probe (A–F) to transverse sections. (A) CS12
and (B) CS14; (C) CS15; (D) CS16. CEP290 transcripts are abundant in the mesonephros (Meso) and metanephros (Meta) of the developing kidney as
well as the spinal cord (Sc). (E, F) A series of sections through mesonephric and metanephric development, respectively, from CS14 to 9 PCW.
Hybridisations were also carried out with CEP290 sense probe as a negative control and no signals were detected (data not shown). CD, collecting
duct; Gl, glomerulus; H, hindgut; Meso, mesonephros; DMeso, degenerating mesonephros; Meta, metanephros; Sc, spinal cord; St, stomach; UL, upper
limb; LL, lower limb. P, renal pelvis. Scale bar: A–D=1 mm; E: CS12–CS16 = 500 mm; CS23= 125 mm F: CS 14= 250 mm; CS17= 125 mm; CS20= 250 mm;
CS22 and 9 PCW=125 mm.
doi:10.1371/journal.pone.0044975.g004
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Cep290 deficiency reveals early post-natal photoreceptor degener-
ation [60] whilst human studies in patients with CEP290 mutations
suggest that whilst there is initial development of rod photorecep-
tors during early development, the distal segments of photorecep-
tors are structurally abnormal after maturation, causing early and
severe loss of visual function typically within the first decade of life
[61]. The retinal expression of CEP290 we have shown during
early development in humans is consistent with a role for CEP290
in photoreceptor cell development.
The expression of both AHI1 and CEP290 in the choroid plexus
is a novel and interesting finding. The choroid plexus produces
cerebrospinal fluid and is circulated through the ventricles of the
brain and the subarachnoid space. The ependymal cells lining the
ventricular space are known to possess motile cilia, and that defects
in these motile cilia can contribute to an obstruction of CSF flow
leading to hydrocephalus [62,63,64,65]. In contrast, the murine
ciliopathy model Tg737orpk demonstrated hydrocephalus before
formation of motile cilia in the ependymal cells [66], implicating
defects in choroid plexus function (such as increased CSF
production) as a primary event in these animals. Primary cilia
are intimately related to the regulation of CSF production. Indeed
clusters of primary cilia on choroid plexus epithelia cells have been
shown to act as chemosensors to regulate CSF production [67].
Upon ahi1 knockdown in zebrafish, we have previously shown
hydrocephalus, alongside other defects associated with a ciliopathy
[49]. A similar appearance, with prominent hydrocephalus was
seen with cep290 (alias nphp6) knockdown in zebrafish [68]. To
date, murine models of Ahi1 and Cep290 knockdown have not
demonstrated gross hydrocephalus. The brain defect that these
mice have revealed includes cerebellar hypoplasia with a vermis/
midline fusion defect early in development [69].
In humans with JSRD, hydrocephalus is a rarer finding,
however recently mutations in the CC2D2A gene (whose protein
product interacts with CEP290 [18]) have been associated with
ventriculomegaly and hydrocephalus [70]. Our experiments
suggest that a functional role for AHI1 and CEP290 is likely
within the developing brain, including the choroid plexus.
A proteomics and interaction mapping project has recently been
published which details a number of important interactions for
both Ahi1 and Cep290 [71]. Mks1, Mks6, and Tectonic1 bind to
Ahi1 protein, which also co-purified with inversin, whilst Cep290
bound strongly with nephrocystin-5. Depletion of nephrocystin-5
had no effect on Cep290 localization, whilst nephrocystin-5 failed
to localize to the centrosome in the absence of Cep290 [71]. The
studies defined 3 protein ‘‘connecting modules’’ where nephro-
cystin proteins 21, 24 and 28 function together at the apical
surface of the cell, nephrocystin-5 and -6 function at the
centrosome and the MKS group of proteins (Mks1, Mks6 and
Tctn2) function in a hedgehog signalling pathway [71]. Ahi1 was
seen as a linking protein between MKS and centrosomal modules.
In an attempt to determine whether Ahi1 is necessary for correct
recruitment of Cep290 to the area around centrosomes, we found
no loss of localisation, which is consistent with Sang’s recently
published localisation data set [71].
In conclusion, we have demonstrated in human development an
expression pattern for AHI1 and CEP290 which includes neuronal,
retinal and renal structures. AHI1 and CEP290 are highly
conserved throughout evolution, but can be expressed and
function independently.
Supporting Information
Supplementary Figure S1 Distribution of ahi1 and
cep290 proteins and cilium and centriole architecture
across eukaryotes. Putative ahi1 and cep290 homologues are
found in organisms that build both motile and sensory cilia. Both
are present in most animals; however ahi1 and cep290 can also
occur individually in organisms. Ultrastructural information was
not available for all organisms included in this study. A ? denotes
an unknown architecture or one where conflicting data have been
reported. Architectures are in accordance with those described in
Simms et al. [49].
(TIF)
Figure 5. Cep290 does not require Ahi1 for localisation to
centrosomes. Immunofluorescence of IMCD3 monolayers co-trans-
fected with siGLO and either negative-control siRNA (A and B), or siRNA
against Ahi1 (A and C). (A) Graph to show centrosome position (gamma
tubulin immunofluorescence, graph expressed as mean +/2 s.e.m.)
from apical to basal in control and Ahi1-silenced cells. Apical refers to
the upper 1.5–2 mm of the cell (the distance between the nuclear
envelope and the plasma membrane in these cells; this is unchanged
following silencing of Ahi1, data not shown). Arrows denote the apical
and mid-cell positions used in B and C. (B and C) Confocal maximum
intensity projections of control (B) and Ahi1-silenced (C) cells showing
Cep290 (red), gamma tubulin (green) and DNA (blue). Transfected cells
were identified using siGLO (yellow). In each case, the top panel
represents an apically-oriented centrosome (position 1 on the graph, A)
and the bottom panel represents a centrosome from the mid-cell
region (position 2 on the graph). Scale bar: 5 mm.
doi:10.1371/journal.pone.0044975.g005
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